igf-1 lr3 before and after + MASS Cycle = CRAZY Growth? #askDave IGF-1 LR3 Peptide Therapy in

10.1016/j.yfrne.2016.12.001 11 DeMorrowS

Although astrocyte reactivity is likely in the first instance to be targeted at maintaining CNS homoeostasis and circuit functions, various mechanisms could alter astrocyte functions in potentially detrimental ways, including (i) persistent reactivity may contribute to chronic neurodegenerative disorders or chronic inflammation, (ii) ageing and cellular senescence which may alter and reduce astrocyte functional capacities, or (iii) genetic mutations in diseased astrocytes or polymorphisms may alter normal astrocyte functions or responses

ASA, American society of anesthesiologists

Of equal concern is the fact that unregulated peptides may be contaminated with impurities, according to the FDA

Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified